
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Progenitor-like exhausted SPRY1+CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma
Zhichao Liu, Yaru Zhang, Ning Ma, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1852-1870.e9
Open Access | Times Cited: 50
Zhichao Liu, Yaru Zhang, Ning Ma, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1852-1870.e9
Open Access | Times Cited: 50
Showing 1-25 of 50 citing articles:
Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer
Yuqing Chen, Dongfang Wang, Yingjie Li, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1268-1285.e7
Open Access | Times Cited: 21
Yuqing Chen, Dongfang Wang, Yingjie Li, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1268-1285.e7
Open Access | Times Cited: 21
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach
Miguel López de Rodas, María Villalba, Miguel F. Sanmamed, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access | Times Cited: 3
Miguel López de Rodas, María Villalba, Miguel F. Sanmamed, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access | Times Cited: 3
Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells
Kevin Wang, Paulina Coutifaris, David Brocks, et al.
Cancer Cell (2024) Vol. 42, Iss. 9, pp. 1582-1597.e10
Closed Access | Times Cited: 10
Kevin Wang, Paulina Coutifaris, David Brocks, et al.
Cancer Cell (2024) Vol. 42, Iss. 9, pp. 1582-1597.e10
Closed Access | Times Cited: 10
The single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma
Zheyi Wang, Yue Zhao, Yang Wo, et al.
Cancer Letters (2024) Vol. 593, pp. 216951-216951
Closed Access | Times Cited: 8
Zheyi Wang, Yue Zhao, Yang Wo, et al.
Cancer Letters (2024) Vol. 593, pp. 216951-216951
Closed Access | Times Cited: 8
Unraveling the tumor microenvironment of esophageal squamous cell carcinoma through single-cell sequencing: A comprehensive review
Lingyu Qi, Jiaxin Wang, Shuang Hou, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189264-189264
Closed Access | Times Cited: 1
Lingyu Qi, Jiaxin Wang, Shuang Hou, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189264-189264
Closed Access | Times Cited: 1
Emerging clinical applications of single-cell RNA sequencing in oncology
Emily Boxer, Nisan Feigin, Roi Tschernichovsky, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access | Times Cited: 1
Emily Boxer, Nisan Feigin, Roi Tschernichovsky, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access | Times Cited: 1
Mechanisms of tumor immunosuppressive microenvironment formation in esophageal cancer
Xiaojun Zhang, Yan Yu, Heping Zhao, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 16, pp. 2195-2208
Open Access | Times Cited: 5
Xiaojun Zhang, Yan Yu, Heping Zhao, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 16, pp. 2195-2208
Open Access | Times Cited: 5
Revolutionizing tumor immunotherapy: unleashing the power of progenitor exhausted T cells
Fang Zhang, Xinyi Ding, Hao Huang, et al.
Cancer Biology and Medicine (2024), pp. 1-14
Open Access | Times Cited: 5
Fang Zhang, Xinyi Ding, Hao Huang, et al.
Cancer Biology and Medicine (2024), pp. 1-14
Open Access | Times Cited: 5
Identification of ferroptosis-related LncRNAs as potential targets for improving immunotherapy in glioblastoma
Zhaochen Wang, Xiao Jin, Xiaoli Yong
Computer Methods in Biomechanics & Biomedical Engineering (2025), pp. 1-13
Closed Access
Zhaochen Wang, Xiao Jin, Xiaoli Yong
Computer Methods in Biomechanics & Biomedical Engineering (2025), pp. 1-13
Closed Access
Molecular Signatures of Cancer Stemness Characterize the Correlations with Prognosis and Immune Landscape and Predict Risk Stratification in Pheochromocytomas and Paragangliomas
Lei Li, Shuangyu Liu, Zeqi Guo, et al.
Bioengineering (2025) Vol. 12, Iss. 3, pp. 219-219
Open Access
Lei Li, Shuangyu Liu, Zeqi Guo, et al.
Bioengineering (2025) Vol. 12, Iss. 3, pp. 219-219
Open Access
Targeting mesothelin-CD24 axis repolarizes tumor-associated macrophages to potentiate PD-1 blockade therapy in high-grade serous ovarian cancer
Y C Zhong, Yiying Wang, Chenyang Wang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e011230-e011230
Open Access
Y C Zhong, Yiying Wang, Chenyang Wang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e011230-e011230
Open Access
Characterization of Novel Mouse Esophageal Squamous Cell Carcinoma Cell Lines and Their Utility as Preclinical Models
Yang Li, Yuhao Wang, Guanzhu Ren, et al.
Cancer Letters (2025), pp. 217600-217600
Closed Access
Yang Li, Yuhao Wang, Guanzhu Ren, et al.
Cancer Letters (2025), pp. 217600-217600
Closed Access
Data‐Driven Molecular Typing: A New Frontier in Esophageal Cancer Management
Yue Du, Bianli Gu, Linlin Shi, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Yue Du, Bianli Gu, Linlin Shi, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Targeting glycolysis in esophageal squamous cell carcinoma: single-cell and multi-omics insights for risk stratification and personalized therapy
Yan Wang, Y. Shi, Xiao Hu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Yan Wang, Y. Shi, Xiao Hu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Current state of cancer immunity cycle: new strategies and challenges of using precision hydrogels to treat breast cancer
Yan Zhu, Yanlin Su, Yaxin Guo, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Yan Zhu, Yanlin Su, Yaxin Guo, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Development of Novel Short Peptide Inhibitor Targeted to Immune Checkpoint PD-1 LBD
Xingyan Zhu, Yuping Wei, Man Zhang, et al.
International Journal of Peptide Research and Therapeutics (2025) Vol. 31, Iss. 3
Closed Access
Xingyan Zhu, Yuping Wei, Man Zhang, et al.
International Journal of Peptide Research and Therapeutics (2025) Vol. 31, Iss. 3
Closed Access
Cross-Talk Between Cancer and Its Cellular Environment—A Role in Cancer Progression
Eliza Turlej, Aleksandra Domaradzka, Justyna Radzka, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 403-403
Open Access
Eliza Turlej, Aleksandra Domaradzka, Justyna Radzka, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 403-403
Open Access
New insights into cancer immune checkpoints landscape from single-cell RNA sequencing
Qian Wang, Jiahui He, Tianyu Lei, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 3, pp. 189298-189298
Closed Access
Qian Wang, Jiahui He, Tianyu Lei, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 3, pp. 189298-189298
Closed Access
Immunosuppressive JAG2+ tumor‐associated neutrophils hamper PD‐1 blockade response in ovarian cancer by mediating the differentiation of effector regulatory T cells
Chenyang Wang, Moran Yang, Y C Zhong, et al.
Cancer Communications (2025)
Open Access
Chenyang Wang, Moran Yang, Y C Zhong, et al.
Cancer Communications (2025)
Open Access
Constructing a Predictive Model for PD-1 Blockade Therapy in Pan-Cancer Based on Machine Learning
Hening Li, S. Li, Liang Xiong, et al.
Research Square (Research Square) (2025)
Closed Access
Hening Li, S. Li, Liang Xiong, et al.
Research Square (Research Square) (2025)
Closed Access
Genomic and Immune Profiling of Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Therapy Versus Upfront Surgery Identifies Novel Immunogenic Cell Death‐Based Signatures for Predicting Clinical Outcomes
Peidong Song, Wenze Tian, Yujia Zheng, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
Peidong Song, Wenze Tian, Yujia Zheng, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
Regulatory T Cell Infiltration-Driven Single-Cell Transcriptomic Analysis Identifies SAP18 as a Prognostic Marker for Esophageal Squamous Cell Carcinoma
Jianxiang Huang, Hanshuo Zhang, Xinyue Lin, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Jianxiang Huang, Hanshuo Zhang, Xinyue Lin, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Cathepsin L promotes oesophageal squamous cell carcinoma development and may be associated with tumour-associated macrophages
Zhenhu Zhang, Jianyu Wang, Yamin Shi, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e29273-e29273
Open Access | Times Cited: 4
Zhenhu Zhang, Jianyu Wang, Yamin Shi, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e29273-e29273
Open Access | Times Cited: 4
A machine learning radiomics based on enhanced computed tomography to predict neoadjuvant immunotherapy for resectable esophageal squamous cell carcinoma
Jialing Wang, Liansha Tang, Xia Zhong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Jialing Wang, Liansha Tang, Xia Zhong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Trem2-expressing multinucleated giant macrophages are a biomarker of good prognosis in head and neck squamous cell carcinoma
Grégoire Gessain, Ahmed-Amine Anzali, Marvin Lerousseau, et al.
Cancer Discovery (2024) Vol. 14, Iss. 12, pp. 2352-2366
Open Access | Times Cited: 4
Grégoire Gessain, Ahmed-Amine Anzali, Marvin Lerousseau, et al.
Cancer Discovery (2024) Vol. 14, Iss. 12, pp. 2352-2366
Open Access | Times Cited: 4